Drug recall

Red Blood Cells, Leukocytes Reduced

FDA recall event 99581 · Class III · Carter BloodCare

Key facts

Event ID 99581
Recall numbers B-0264-2026
Recalling firm Carter BloodCare
Product type Biologics
Products Red Blood Cells, Leukocytes Reduced
Classification Class III
Status Terminated
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Red Blood Cells, Leukocytes Reduced, which were leukoreduced by filtration at an unacceptable temperature, were distributed.
Initiation date Jun 16, 2025
Report date Sep 30, 2026
Termination date Sep 22, 2026
City Bedford
State TX
Country United States
FEI number 3002603147

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls